These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 15293275)

  • 1. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
    Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
    Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
    Willison HJ; Plomp JJ
    Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
    Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
    Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N; Kuwabara S
    J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
    Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
    Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.
    He L; Zhang G; Liu W; Gao T; Sheikh KA
    J Neurosci; 2015 Apr; 35(17):6770-85. PubMed ID: 25926454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.